Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,117.9
-26.3 (-0.84%)

 

  • STI Straits Times Index
    3,117.9
    -26.3 (-0.84%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,572.2
    -16.8 (-1.06%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,489.0
    -312.3 (-1.08%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,529.2
    4.1 (0.12%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,010.9
    -953.2 (-3.29%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,996.3
    -10.9 (-0.18%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,483.1M
  • Value: 1,385.6M
  • Rise: 115
  • Fall: 235
  • Unch: 413

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.193-0.001
MC Payment0.585+0.085
MarcoPolo Marine0.030-
Shen Yao0.007-
Pan Asian0.074+0.013
ThaiBev0.700-0.010
Advanced Systems0.001-
Singtel2.290-0.020
Metal Component0.061-0.005
Genting Sing0.870-0.015

World Indices

World Indices
Name Last Change
Nasdaq 14,030.4 -131.0
HSI 28,489.0 -312.3
HSCEI 10,547.9 -98.5
Jakarta 5,996.3 -10.9
Nikkei 225 28,010.9 -953.1
SSE Comp 3,529.2 +4.1
Shanghai A 3,699.2 +4.3
Shanghai B 250.7 -0.4
KOSPI 3,240.8 -27.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Diagnos Laboratorium Utama Tbk. Diagnos Laboratorium Utama Tbk.
Quotes 10 Minutes Delayed. Updated at 21 Jun 2021 15:15
Last (IDR): 1,415.000 Change: +235.000 High: 1,445.000 Remarks: -
Change (%): +19.92 Low: 1,165.000
Open 1,190.000 Yesterday's Close 1180.000
Buy Price 1410.000 Sell Price 1415.000
Buy Volume ('000) 201 Sell Volume ('000) 112.7
Cumulative Volume ('000) 50,674.6 Cumulative Value 69,007,396,500
Click to show Stock Prices chart

Key Statistics

EPS (IDR) a 42.14923 Trailing EPS (IDR) e 42.14923 NAV (IDR) b 131.0178
PE a 33.571 Trailing PE f 33.571 Price / NAV b 10.8001
Dividend (IDR) d - Cash In Hand (IDR) g 51.4291 Issued & Paid-up Shares c 1,250,000,000
Dividend Yield (%) d - Price / Cash In Hand g 27.514 Treasury Shares h -
Beta - 75 Daysi 0.340 R-Squared - 75 Days(%)i 0.34 Market Cap (M) 1,768,750.000
Beta - 500 Daysi -0.982 R-Squared - 500 Days (%)i 0.93 Enterprise Value (M) 1,707,091.048
Piotroski F Score 8 Exchange Code DGNS Par Value ( IDR ) 25.00000
52 Weeks Volatility (%) n.a. 6-Month VWAP n.a. Free Float (%) 20.0
Sector & Industry Health Services - Medical/Nursing Services
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 18 Jan 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 18 Jan 2021.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Diagnos Laboratorium Utama Tbk. IDX 1,768,750.000 33.571 33.571 10.8001 -
Industry Medical/Nursing Services IDX 6,755,750.000 201.666 201.666 3.9123 -
Local Peer Metro Healthcare Indonesia Tbk. IDX 12,568,500.000 878.130 878.127 3.8204 -
Global Peer JD HEALTH HKEx 338,498.531 - - 7.2737 -
Global Peer FRESENIUS MEDICAL CARE AG & CO KGAA SPON ADR-EACH REP 0.5 NPV NYSE 24,323.496 18.325 18.560 1.7249 1.380
Global Peer AGILON HEALTH INC NYSE 16,903.527 - - -56.6916 -
Global Peer OAK STREET HEALTH INC NYSE 13,495.831 - - 49.4879 -
Global Peer SONIC HEALTHCARE ASX 18,069.662 34.239 19.001 3.0998 2.235
Global Peer PA GOODDOCTOR HKEx 100,961.520 - - 5.3782 -
Global Peer DAVITA INC NYSE 12,917.106 16.491 16.328 10.3494 -
Global Peer GUARDANT HEALTH INC NASDAQ 12,154.744 - - 14.3495 -
Global Peer LIFESTANCE HEALTH GROUP INC NASDAQ 9,793.340 - - 10.2655 -
Global Peer NATERA INC NASDAQ 9,047.679 - - 24.2928 -
Other Global Peers AMEDISYS INC (NASDAQ), CHEMED CORP (NYSE), INVITAE CORP (NYSE), JXR (HKEx), LHC GROUP INC (NASDAQ), ACADIA HEALTHCARE (NASDAQ), NEOGENOMICS INC (NASDAQ), 1LIFE HEALTHCARE INC (NASDAQ), ENSIGN GROUP INC (NASDAQ), NH HEALTH-B (HKEx), OPTION CARE HEALTH INC (NASDAQ), SMILEDIRECTCLUB INC (NASDAQ), MEDNAX INC (NYSE), BURNING ROCK BIOTECH LTD SPON ADS EACH REP 1 ORD SHS CL A (NASDAQ), AVEANNA HEALTHCARE HOLDINGS INC (NASDAQ), FULGENT GENETICS INC (NASDAQ), HEALIUS LTD (ASX), EC HEALTHCARE (HKEx), GENETRON HOLDINGS LIMITED SPON ADS EACH REP 5 ORD SHS (NASDAQ), CASTLE BIOSCIENCES INC (NASDAQ), RADNET INC (NASDAQ), US PHYSICAL THERAPY (NYSE), C-MER EYE (HKEx), TIVITY HEALTH INC (NASDAQ), SVH (SET), ADDUS HOMECARE CORP (NASDAQ), PENNANT GROUP INC (NASDAQ), KPJ (Bursa), RAM (SET), APRIA INC (NASDAQ), HANGER INC (NYSE), UPHEALTH INCORPORATED (NYSE), FINCH THERAPEUTICS GROUP INC (NASDAQ), OCEANIA HEALTHCARE LTD (ASX), GLOBAL CORD BLOOD CORPORATION (NYSE), ONTRAK INC (NASDAQ), AUSTRALIAN CLINICA (ASX), EUROEYES (HKEx), BIODESIX INC (NASDAQ), TalkMed (SGX), TOWN HEALTH (HKEx), VIRTUS HEALTH LIMITED (ASX), GLOBAL X FDS ARTIFICIAL INTELLIGENCE AND TECH ETF (NASDAQ), CARDIFF ONCOLOGY INC (NASDAQ), EXAGEN INC (NASDAQ), CLOVER CORP (ASX), SANARA MEDTECH INC (NASDAQ), APTINYX INC (NASDAQ), AKUMIN INC (NASDAQ), GREENBROOK TMS INC (NASDAQ), OPTINOSE INC (NASDAQ), AESTHETIC MEDICAL INT HLDGS GRP LTD SPON ADS EACH REP 3 ORD SHS (NASDAQ), PROGENITY INC (NASDAQ), SILK LASER AUSTRALIA LTD (ASX), KANGHUA HEALTH (HKEx), HEALTHIA LTD (ASX), RAILY AESMED (HKEx), ONCOSEC MEDICAL INCORPORATED (NASDAQ), BARD1 LIFE SCIENCES LTD (ASX), PRO-DEX INC (NASDAQ), UMP (HKEx), SPLASH BEVERAGE GROUP INC (NYSE American), OPTIMAX (Bursa), CAPITAL SENIOR LIVING CORP (NYSE), ORTHOCELL LIMITED (ASX), Cordlife (SGX), CONCORD MEDICAL SERVICES HLDGS LTD ADS EACH 1 REPR 3 ORD SHS (USD0.0001) (NYSE), KATO (HK) HLDGS (HKEx), Clearbridge (SGX), NOVO INTEGRATED SCIENCES INC (NASDAQ), Asian Healthcare (SGX), BIOCEPT INC (NASDAQ), GBS INC (NASDAQ), HC Surgical (SGX), KDH (SET), IMAC HOLDINGS INC (NASDAQ), HUMAN HEALTH (HKEx), GUARDION HEALTH SCIENCES INC (NASDAQ), CHINA HEALTH (HKEx), D (SET), Alliance HC (SGX), TOTAL BRAIN LTD (ASX), Sing Paincare (SGX), RMH HOLDINGS (HKEx), Medinex (SGX), WAH YAN-NEW (HKEx), AMERICAN SHARED HOSPITAL SERVICES (NYSE American), SMILE (Bursa), AsiaMedic (SGX), LIFESPOT HEALTH LTD (ASX), RHT HealthTrust (SGX), MEDINET GROUP (HKEx), REPUBLIC HC (HKEx), MOHO RESOURCES NL (ASX), TOPVISN (Bursa), SMILES INCLUSIVE LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+355.000
+33.49 %
10 Days -+365.000
+34.76 %
20 Days -+675.000
+91.22 %
Medium Term Return 3 Months -+730.000
+106.57 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 270.000 - 1,250.000 Change From 1 Year Low +1145.000 % Change From 1 Year Low (%) +424.07
Change From 1 Year High +165.000 % Change From 1 Year High (%) +13.20
2 Years Range 270.000 - 1,250.000 Change From 2 Years Low +1145.000 % Change From 2 Years Low (%) +424.07
Change From 2 Years High +165.000 % Change From 2 Years High (%) +13.20
5 Years Range 270.000 - 1,250.000 Change From 5 Years Low +1145.000 % Change From 5 Years Low (%) +424.07
Change From 5 Years High +165.000 % Change From 5 Years High (%) +13.20
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

PT Diagnos Laboratorium Utama Tbk engages in the provision of medical laboratory testing services. It offers anatomic pathology, chemistry immunology, clinical microscopy, hematology microbiology, 2D echo, CT Scan, electrocardiogram, impedance cardiography, mammography, ultrasound, vascular studies, X-ray, and polymerase chain reaction (“PCR”) tests. The company was founded on August 29, 2009 and is headquartered in Jakarta, Indonesia.

Historical Price Data

Date Open High Low Close Volume VWAP
18 Jun 2021 1210.000 1250.000 1140.000 1180.000 16,336,000 1200.7404
17 Jun 2021 1045.000 1210.000 1045.000 1210.000 20,393,400 1157.3052
16 Jun 2021 1010.000 1110.000 1010.000 1040.000 16,018,800 1056.5901
15 Jun 2021 1020.000 1020.000 975.000 1010.000 13,092,600 1004.9958
14 Jun 2021 1060.000 1075.000 1005.000 1020.000 14,023,900 1038.4906
11 Jun 2021 1080.000 1130.000 1025.000 1060.000 13,353,600 1100.0736
10 Jun 2021 1190.000 1230.000 1100.000 1100.000 19,480,800 1166.9606
09 Jun 2021 1065.000 1210.000 1050.000 1180.000 21,280,800 1132.7351
08 Jun 2021 1075.000 1075.000 1035.000 1065.000 16,104,000 1058.0059
07 Jun 2021 1060.000 1080.000 1035.000 1065.000 9,699,900 1062.4590
04 Jun 2021 1090.000 1110.000 1025.000 1050.000 11,438,900 1064.5919
03 Jun 2021 970.000 1055.000 965.000 1045.000 25,159,000 1018.0209
02 Jun 2021 980.000 990.000 950.000 970.000 8,538,900 970.3910
31 May 2021 970.000 1025.000 955.000 975.000 14,746,800 990.6650
28 May 2021 935.000 975.000 870.000 960.000 24,519,000 932.4616
27 May 2021 1010.000 1050.000 935.000 935.000 20,285,100 969.8180
25 May 2021 950.000 1145.000 950.000 1005.000 58,861,200 1052.3636
24 May 2021 750.000 925.000 750.000 925.000 45,989,000 878.2210
21 May 2021 775.000 830.000 740.000 740.000 35,280,900 775.1577
20 May 2021 705.000 780.000 695.000 770.000 21,283,500 756.5795
19 May 2021 700.000 740.000 680.000 705.000 26,671,000 708.7590
18 May 2021 650.000 665.000 625.000 665.000 22,107,700 652.3646
Summary
Current 2 Weeks
(07 Jun 2021 to 18 Jun 2021)
1060.000 1250.000 975.000 1180.000 159,783,800 -
Previous 2 Weeks
(20 May 2021 to 04 Jun 2021)
705.000 1250.000 695.000 1050.000 266,102,300 -
4 Weeks from
(19 Apr 2021 to 19 May 2021)
560.000 1250.000 560.000 705.000 515,424,800 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.